Showing results (571-580 of 631) with videos related to
Sort By:
Pageof 64
Molecular Therapy. Methods & Clinical Development|March 5, 2021
Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease miceKatherine A White, Hemanth R Nelvagal, Timothy A Poole, et al.Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|March 19, 2021
Childhood obesity prevention across borders: A National Institutes of Health commentarySusan Vorkoper, S Sonia Arteaga, David Berrigan, et al.Military Medicine|April 11, 2025
Comorbid Chronic Pain and Posttraumatic Stress Disorder Among Veterans: Approaches to CareAlessandra A Pratt, Jennifer Van Tiem, Brian C Lund, et al.Journal of Virology|December 1, 1996
Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrenceK M Hehir, D Armentano, L M Cardoza, et al.Frontiers in Genetics|April 10, 2023
Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 diseaseTyler B Johnson, Jon J Brudvig, Shibi Likhite, et al.Journal of Neuroscience Methods|August 10, 2014
DARPA-funded efforts in the development of novel brain-computer interface technologiesRobbin A Miranda, William D Casebeer, Amy M Hein, et al.Nature Structural & Molecular Biology|August 19, 2020
Large-scale tethered function assays identify factors that regulate mRNA stability and translationEn-Ching Luo, Jason L Nathanson, Frederick E Tan, et al.Cell Reports|April 13, 2016
Enhanced CLIP Uncovers IMP Protein-RNA Targets in Human Pluripotent Stem Cells Important for Cell Adhesion and SurvivalAnne E Conway, Eric L Van Nostrand, Gabriel A Pratt, et al.Translational Psychiatry|May 20, 2015
Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1N Dawson, M Kurihara, D M Thomson, et al.Bioorganic & Medicinal Chemistry Letters|February 24, 2007
M4 agonists/5HT7 antagonists with potential as antischizophrenic drugs: serominic compoundsColin J Suckling, John A Murphy, Abedawn I Khalaf, et al.Pageof 64